Wall Street wary of untested strategy in CVS-Aetna megamerger

AETNA INC.'S STOCK has been trading below CVS Health Corp.'s proposed acquisition price, revealing a market skepticism in the deal's viability. / BLOOMBERG FILE PHOTO /MICHAEL NAGLE
AETNA INC.'S STOCK has been trading below CVS Health Corp.'s proposed acquisition price, revealing a market skepticism in the deal's viability. / BLOOMBERG FILE PHOTO /MICHAEL NAGLE
NEW YORK - The success of CVS Health Corp.’s $69 billion acquisition of health insurer Aetna Inc. rides on a bet on a complex and untested strategy, and some in Wall Street are questioning whether the companies can pull it off. CVS plans to build mini health centers in some of its 9,700 stores, turning them…
To read the full story, Subscribe or
Subscribe to PBN
- Advertisement -